Rankings
▼
Calendar
HRTX Q3 2023 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31M
+18.4% YoY
Gross Profit
$13M
42.1% margin
Operating Income
-$25M
-79.3% margin
Net Income
-$25M
-79.6% margin
EPS (Diluted)
$-0.17
QoQ Revenue Growth
-1.0%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$229M
Total Liabilities
$257M
Stockholders' Equity
-$28M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$27M
+18.4%
Gross Profit
$13M
$12M
+11.7%
Operating Income
-$25M
-$42M
+40.5%
Net Income
-$25M
-$42M
+40.3%
← FY 2023
All Quarters
Q4 2023 →